ライフサイエンスコーパス: antimicrobial susceptibility testing

1 y of an isolate allows for strain typing and antimicrobial susceptibility testing).

2 phoresis, extended virulence genotyping, and antimicrobial susceptibility testing.

3 demonstrated an added value for LC-MS/MS in antimicrobial susceptibility testing.

4 ria promulgated by the European Committee on Antimicrobial Susceptibility Testing.

5 Antimicrobial susceptibility testing.

6 t bacilli smears, and microbial cultures and antimicrobial susceptibility testing.

7 nating the need for biochemical analysis and antimicrobial susceptibility testing.

8 ime needed for phenotypic identification and antimicrobial susceptibility testing.

9 gel electrophoresis (PFGE), serotyping, and antimicrobial susceptibility testing.

10 quence typing (MLST), plasmid profiling, and antimicrobial susceptibility testing.

11 ted by the NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing.

12 tion's External Quality Assurance System for Antimicrobial Susceptibility Testing.

13 Agar dilution was used to conduct antimicrobial susceptibility testing.

14 -genome short-read sequencing and additional antimicrobial susceptibility testing.

15 y Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing.

16 cal yet reproducible methods for cefiderocol antimicrobial susceptibility testing.

17 to broth microdilution (BMD) for performing antimicrobial susceptibility testing.

18 nezolid and moxifloxacin based on phenotypic antimicrobial susceptibility testing.

19 breakpoints set by the European Committee on Antimicrobial Susceptibility Testing.

20 and was approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing.

21 serotyping, multilocus sequence typing, and antimicrobial susceptibility testing.

22 sm identification and automated-system-based antimicrobial susceptibility testing.

23 for broad-based bacterial identification or antimicrobial susceptibility testing.

24 nce of accurate organism identification, and antimicrobial susceptibility testing.

25 bolic profiling provides an avenue for rapid antimicrobial susceptibility testing.

26 tandards Institute and European Committee on Antimicrobial Susceptibility Testing agree that carbapen

27 Typhi strains has emerged worldwide, making antimicrobial susceptibility testing an important functi

28 s of 2004 to 2005 and 2009 to 2010 underwent antimicrobial susceptibility testing and characterizatio

29 or additional characterization that included antimicrobial susceptibility testing and detection of fi

30 pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility testing and examined for th

31 In vitro antimicrobial susceptibility testing and in silico ident

32 ne can expect to see changes in guidance for antimicrobial susceptibility testing and interpretation.

33 Isolates of C. difficile underwent antimicrobial susceptibility testing and molecular typin

34 Antimicrobial susceptibility testing and pulsed-field ge

35 Antimicrobial susceptibility testing and pulsed-field ge

36 istance mechanisms in staphylococci, current antimicrobial susceptibility testing and reporting recom

37 Isolates underwent antimicrobial susceptibility testing and subtyping by pu

38 Antimicrobial susceptibility testing and whole genome se

39 We performed antimicrobial susceptibility testing and whole genome se

40 tion at a single cancer center and performed antimicrobial susceptibility testing and whole-genome se

41 ons citrate agar medium and characterised by antimicrobial susceptibility testing and whole-genome se

42 Phenotypic antimicrobial susceptibility testing and whole-genome se

43 ovides an effective quantitative measure for antimicrobial susceptibility testing, and determination

44 e now using WGS for pathogen identification, antimicrobial susceptibility testing, and epidemiologica

45 by the VITEK 2 system for identification and antimicrobial susceptibility testing, and the results we

46 terized with routine identification systems, antimicrobial susceptibility testing, and whole-genome s

47 Serotyping, antimicrobial susceptibility testing, and whole-genome s

48 Serotyping/grouping, antimicrobial susceptibility testing, and/or whole genom

49 In January 2015, the CLSI Subcommittee on Antimicrobial Susceptibility Testing approved these rang

50 n methods and the lengthy turnaround time of antimicrobial susceptibility testing are significant bar

51 which were outside of the United States, for antimicrobial susceptibility testing as part of the Worl

52 y Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing (AST SC) is a volun

53 Accurate antimicrobial susceptibility testing (AST) and appropria

54 Accurate antimicrobial susceptibility testing (AST) and reporting

55 Here, we report a single cell antimicrobial susceptibility testing (AST) approach for

56 stance genotype with quantitative phenotypic antimicrobial susceptibility testing (AST) are scarce.

57 , from 56 patients, classified by phenotypic antimicrobial susceptibility testing (AST) as showing re

58 system for rapid pathogen classification and antimicrobial susceptibility testing (AST) at the single

59 Accurate and timely performance of antimicrobial susceptibility testing (AST) by the clinic

60 Routine antimicrobial susceptibility testing (AST) can prevent d

61 As a result, AZI antimicrobial susceptibility testing (AST) cannot be int

62 ned the completed survey, 393 (78%) reported antimicrobial susceptibility testing (AST) capacity and

63 Traditional antimicrobial susceptibility testing (AST) confirmed a h

64 . Food and Drug Administration (FDA)-cleared antimicrobial susceptibility testing (AST) devices compa

65 red in vitro diagnostic automated system for antimicrobial susceptibility testing (AST) directly from

66 The long turnaround time in antimicrobial susceptibility testing (AST) endangers pat

67 Clinical justification for rapid antimicrobial susceptibility testing (AST) in Gram-negat

68 As such, antimicrobial susceptibility testing (AST) is a cornerst

69 Antimicrobial susceptibility testing (AST) is a fundamen

70 Antimicrobial susceptibility testing (AST) is an essenti

71 a identification (ID) and rapid yet reliable antimicrobial susceptibility testing (AST) is developed.

72 The speed of conventional antimicrobial susceptibility testing (AST) is intrinsica

73 Antimicrobial susceptibility testing (AST) is not routin

74 Antimicrobial susceptibility testing (AST) is often used

75 Antimicrobial susceptibility testing (AST) is required f

76 A sufficiently fast and simple antimicrobial susceptibility testing (AST) is urgently r

77 ds and guidelines (among other products) for antimicrobial susceptibility testing (AST) methods and r

78 Conventional antimicrobial susceptibility testing (AST) methods requi

79 Previously, interpretative criteria and antimicrobial susceptibility testing (AST) methods speci

80 ating an urgent need for rapid and sensitive antimicrobial susceptibility testing (AST) methods to gu

81 Three commercial antimicrobial susceptibility testing (AST) methods were

82 Current antimicrobial susceptibility testing (AST) methods, howe

83 oenix system for the identification (ID) and antimicrobial susceptibility testing (AST) of 251 isolat

84 At present, in vitro antimicrobial susceptibility testing (AST) of aztreonam-

85 Antimicrobial susceptibility testing (AST) of cefideroco

86 Sparks, MD) for the identification (ID) and antimicrobial susceptibility testing (AST) of challenge

87 Antimicrobial susceptibility testing (AST) of clinical i

88 signed for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically

89 Antimicrobial susceptibility testing (AST) of pneumococc

90 Accurate and reproducible antimicrobial susceptibility testing (AST) of polymyxin

91 Identification (ID) and antimicrobial susceptibility testing (AST) of respirator

92 Antimicrobial susceptibility testing (AST) of these isol

93 Antimicrobial susceptibility testing (AST) of these prob

94 Our objective was to assess whether certain antimicrobial susceptibility testing (AST) profiles can

95 Antimicrobial susceptibility testing (AST) provides valu

96 id and reliable bacterial identification and antimicrobial susceptibility testing (AST) remain challe

97 Antimicrobial susceptibility testing (AST) reporting and

98 Current gold-standard antimicrobial susceptibility testing (AST) requires exte

99 Among 47 isolates from patients with antimicrobial susceptibility testing (AST) results avail

100 Median time to antimicrobial susceptibility testing (AST) results decre

101 rovide rapid species identification (ID) and antimicrobial susceptibility testing (AST) results for t

102 The present study compared the antimicrobial susceptibility testing (AST) results gener

103 culture with microbial growth accompanied by antimicrobial susceptibility testing (AST) results in th

104 Concurrently, species, temporal trends, and antimicrobial susceptibility testing (AST) results of Le

105 ast majority of bacterial identification and antimicrobial susceptibility testing (AST) results were

106 stem (AXDX) provides identification (ID) and antimicrobial susceptibility testing (AST) results withi

107 ation by MALDI-TOF MS and valid and accurate antimicrobial susceptibility testing (AST) results.

108 Based on these data, the CLSI antimicrobial susceptibility testing (AST) subcommittee

109 boring MRSA, including three (semi)automated antimicrobial susceptibility testing (AST) systems and f

110 Antimicrobial susceptibility testing (AST) systems are t

111 Antimicrobial susceptibility testing (AST) technologies

112 stance has prompted the development of rapid antimicrobial susceptibility testing (AST) technologies

113 ormance of the VITEK REVEAL, system for fast antimicrobial susceptibility testing (AST) to convention

114 sistant Klebsiella pneumoniae demands faster antimicrobial susceptibility testing (AST) to guide anti

115 Isolates underwent antimicrobial susceptibility testing (AST) using Etest.

116 ution melt (HRM), as well as pheno-molecular antimicrobial susceptibility testing (AST) via PCR.

117 atory practice in the preanalytical phase of antimicrobial susceptibility testing (AST) was evaluated

118 report form was completed for each case and antimicrobial susceptibility testing (AST) was performed

119 determining the optimal frequency of repeat antimicrobial susceptibility testing (AST) when an organ

120 Antimicrobial susceptibility testing (AST) with 13 agent

121 Rapid antimicrobial susceptibility testing (AST) would decreas

122 ISA (hVISA) are pathogens for which accurate antimicrobial susceptibility testing (AST) would rule ou

123 harmacokinetics (PK), pharmacodynamics (PD), antimicrobial susceptibility testing (AST), and how thes

124 AMR is identified through antimicrobial susceptibility testing (AST), but current

125 k of a rapid pathogen identification (ID) or antimicrobial susceptibility testing (AST), resulting in

126 e activities of the microbiology laboratory, antimicrobial susceptibility testing (AST), to illustrat

127 phokinetic bacterial analysis for phenotypic antimicrobial susceptibility testing (AST), with promisi

128 assay was adapted for use in broad-spectrum antimicrobial susceptibility testing (AST).

129 ng with the ability to perform culture-based antimicrobial susceptibility testing (AST).

130 AMR are clinical laboratories, which perform antimicrobial susceptibility testing (AST).

131 th microdilution (BMD) method for performing antimicrobial susceptibility testing (AST).

132 h micro-dilution (BMD) method for performing antimicrobial susceptibility testing (AST).

133 sequencing bacterial strains and performing antimicrobial susceptibility testing (AST).

134 orimetric sensing strategy was developed for antimicrobial susceptibility testing (AST).

135 ottle for use with downstream disk diffusion antimicrobial susceptibility testing (AST).

136 ogram results were compared to culture-based antimicrobial susceptibility testing (AST).

137 which requires bacterial identification and antimicrobial susceptibility testing (AST).

138 ial workup [e.g., identification (ID) and/or antimicrobial susceptibility testing (AST)] of bacterial

139 factor is the 18-24 h of incubation prior to antimicrobial-susceptibility testing (AST) recommended b

140 n and facilitates rapid bacterial growth for antimicrobial susceptibility testing at the point of car

141 large surface-to-volume ratio, toward rapid antimicrobial susceptibility testing at the point of car

142 dy were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing at their June 2015

143 simple microfluidic device that can perform antimicrobial susceptibility testing automatically via a

144 with an MIC above the European Committee on Antimicrobial Susceptibility Testing breakpoint) when ac

145 ndards Institute revised the fluoroquinolone antimicrobial susceptibility testing breakpoints for bot

146 o 21.7%) using CLSI or European Committee on Antimicrobial Susceptibility Testing breakpoints.

147 Antimicrobial susceptibility testing, broth enriched cul

148 All isolates were identified and underwent antimicrobial susceptibility testing by broth microdilut

149 CRE isolates underwent antimicrobial susceptibility testing by broth microdilut

150 through 10 May 2016 underwent routine Etest antimicrobial susceptibility testing by the Hawaii Depar

151 enotypic analysis, including biochemical and antimicrobial susceptibility testing, cellular fatty aci

152 Here, we show that personalised antimicrobial susceptibility testing could help tackle a

153 em, were determined by the dielectrophoretic antimicrobial susceptibility testing (dAST) and by the c

154 important implications for interpretation of antimicrobial susceptibility testing data and may be imp

155 Notably, antimicrobial susceptibility testing demonstrated good o

156 support from technical representatives from antimicrobial susceptibility testing device manufacturer

157 As such, our antimicrobial susceptibility testing diagnostic and surv

158 or =1 microg/ml by the European Committee on Antimicrobial Susceptibility Testing]; disk diffusion br

159 tion's External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST) from Jan

160 ed in this article, the CLSI Subcommittee on Antimicrobial Susceptibility Testing established new bre

161 ptibility testing, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Cl

162 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) are 2 glob

163 ntly, clinical FDA and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint

164 When evaluated using European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint

165 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth micr

166 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) epidemiolo

167 stitute (CLSI)-FDA and European Committee on Antimicrobial Susceptibility Testing (EUCAST) interpreti

168 s Institute (CLSI) and European Committee of Antimicrobial Susceptibility Testing (EUCAST) methodolog

169 k breakpoints, and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) S. pseudin

170 on (BMD) method of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) was compar

171 stitute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST), respectiv

172 inistration (FDA), and European Committee on Antimicrobial Susceptibility Testing (EUCAST).

173 e data collated by the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

174 stitute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

175 Antimicrobial susceptibility testing expense may be a si

176 Bacteria were identified by MALDI-TOF, antimicrobial susceptibility testing followed EUCAST gui

177 ionization-time of flight mass spectrometry, antimicrobial susceptibility testing followed European C

178 enterococci following a laboratory change in antimicrobial susceptibility testing from disk diffusion

179 Accelerating antimicrobial susceptibility testing from positive blood

180 ility testing followed European Committee on Antimicrobial Susceptibility Testing guidelines.

181 The NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing has recently approv

182 ofluidic device provides a simple method for antimicrobial susceptibility testing in an automated for

183 ds were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing in January 2015 and

184 to 0.5/4 mug/mL) by the CLSI Subcommittee on Antimicrobial Susceptibility Testing in January 2022.

185 terobacteriaceae family poses a challenge to antimicrobial susceptibility testing in the clinical lab

186 Antimicrobial susceptibility testing in the presence of

187 tandards Institute and European Committee on Antimicrobial Susceptibility Testing interpretative stan

188 Antimicrobial susceptibility testing is a critical compo

189 Antimicrobial susceptibility testing is a critical compo

190 Antimicrobial susceptibility testing is a key weapon aga

191 The applicability of microfluidic rapid antimicrobial susceptibility testing is demonstrated in

192 Because antimicrobial susceptibility testing is not routinely do

193 Antimicrobial susceptibility testing is routinely perfor

194 Accurate antimicrobial susceptibility testing is vital for patien

195 Antimicrobial-susceptibility testing is performed to det

196 Current planktonic-based antimicrobial susceptibility testing lacks the ability t

197 annual update, the Performance Standards for Antimicrobial Susceptibility Testing (M100).

198 f identification to bacterial species level, antimicrobial susceptibility testing, macrolide resistan

199 In conclusion, using a reference antimicrobial susceptibility testing method and a geneti

200 atory Standards Institute (CLSI) revised the antimicrobial susceptibility testing method for telavanc

201 should consider using a second, independent antimicrobial susceptibility testing method to validate

202 Each organism was tested by the routine antimicrobial susceptibility testing method used by each

203 train was tested by the laboratory's routine antimicrobial susceptibility testing method.

204 g was performed by the European Committee on Antimicrobial Susceptibility Testing methodology.

205 up organisms on the selection of appropriate antimicrobial susceptibility testing methods and interpr

206 owever, existing culture-based and PCR-based antimicrobial susceptibility testing methods are far too

207 Diffusion-based antimicrobial susceptibility testing methods are not rec

208 d be aware of the significant limitations of antimicrobial susceptibility testing methods for BCC.

209 However, the accuracy of some antimicrobial susceptibility testing methods for detecti

210 To assess the abilities of various antimicrobial susceptibility testing methods to detect E

211 ploying accurate, reproducible, and feasible antimicrobial susceptibility testing methods to guide ap

212 achieved 95% overall agreement with standard antimicrobial susceptibility testing methods, with the h

213 WGS was as sensitive and specific as routine antimicrobial susceptibility testing methods.

214 me geographic area using broth microdilution antimicrobial susceptibility testing, multilocus sequenc

215 Significantly, the results of antimicrobial susceptibility testing obtained for our is

216 Antimicrobial susceptibility testing of 53 strains, incl

217 Antimicrobial susceptibility testing of 66 isolates reve

218 uencing, comprehensive genomic analysis, and antimicrobial susceptibility testing of 66 MAC clinical

219 uld be developed, and the optimal method for antimicrobial susceptibility testing of A. xylosoxidans

220 ed literature for all publications detailing antimicrobial susceptibility testing of B. anthracis.

221 Thus, the antimicrobial susceptibility testing of B. pertussis can

222 Present methods of antimicrobial susceptibility testing of Bordetella pertu

223 tion and the agar disk diffusion methods for antimicrobial susceptibility testing of Campylobacter we

224 methods were used in the identification and antimicrobial susceptibility testing of E. coli from cli

225 t represents an accurate tool for performing antimicrobial susceptibility testing of Enterobacterales

226 Antimicrobial susceptibility testing of isolates from 47

227 as been used to reduce the time required for antimicrobial susceptibility testing of Mycobacterium tu

228 s for the performance and quality control of antimicrobial susceptibility testing of Mycoplasma pneum

229 methods decrease the time to identification/antimicrobial susceptibility testing of S. aureus and de

230 ods take several days for identification and antimicrobial susceptibility testing of staphylococcal i

231 in S. aureus, Vitek 2 performed reliably for antimicrobial susceptibility testing of staphylococci an

232 It appears to be an acceptable method for antimicrobial susceptibility testing of staphylococci an

233 Seven commercial systems for antimicrobial susceptibility testing of Streptococcus pn

234 control limits and interpretive criteria for antimicrobial susceptibility testing of Streptococcus pn

235 In vitro antimicrobial susceptibility testing of the conjugate ag

236 Antimicrobial susceptibility testing of the samples iden

237 Antimicrobial susceptibility testing of these cobalt com

238 onas maltophilia at this time, and, as such, antimicrobial susceptibility testing of these organisms

239 lity control (QC) standards for the in vitro antimicrobial susceptibility testing of two fastidious v

240 The utility of Etest for antimicrobial susceptibility testing of Yersinia pestis

241 We performed antimicrobial susceptibility testing on all 2767 sero19A

242 Culture, antimicrobial susceptibility testing, P1 subtyping, and

243 6%) included >=1 carbapenem on their primary antimicrobial susceptibility testing panel, and approxim

244 A bloodstream isolates were characterized by antimicrobial susceptibility testing, PCR analysis of vi

245 Isolates were serotyped and antimicrobial susceptibility testing performed.

246 e isolates were characterized by serotyping, antimicrobial-susceptibility testing, phage typing, and

247 Here, we present a capillary-based antimicrobial susceptibility testing platform (cAST), a

248 For genotypic antimicrobial susceptibility testing prediction, the per

249 The isolates underwent antimicrobial susceptibility testing, pulsed-field gel e

250 ble S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel e

251 The delayed reporting of antimicrobial susceptibility testing remains a limiting

252 tanding about how best to prepare cumulative antimicrobial susceptibility testing reports (CASTRs) to

253 ysis interpretation, culture thresholds, and antimicrobial susceptibility testing, require special co

254 ) CD-ROM on AST, and (iv) the CDC Multilevel Antimicrobial Susceptibility Testing Resource website.

255 high degree of correlation of serotyping and antimicrobial susceptibility testing results between fou

256 increased the importance of having accurate antimicrobial susceptibility testing results for guiding

257 We compared the antimicrobial susceptibility testing results generated b

258 logical testing, including interpretation of antimicrobial susceptibility testing results using curre

259 tem (AXDX) provides rapid identification and antimicrobial susceptibility testing results.

260 Antimicrobial susceptibility testing revealed several di

261 Antimicrobial susceptibility testing revealed universal

262 tant but clindamycin susceptible by in vitro antimicrobial susceptibility testing should be tested fo

263 Based on these findings, we recommend that antimicrobial susceptibility testing should not be routi

264 Antimicrobial susceptibility testing showed that oxazoli

265 al and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Subcommittee evalua

266 ified selection for changes in motility, and antimicrobial susceptibility testing suggested that the

267 nc., Durham, NC) is a widely used commercial antimicrobial susceptibility testing system.

268 leading organizations that set standards for antimicrobial susceptibility testing, the European Commi

269 apid ID 32 Strep identification methods, and antimicrobial susceptibility testing to determine their

270 tween pwCF and providers, the limitations of antimicrobial susceptibility testing to predict treatmen

271 d characterization methods, from traditional antimicrobial susceptibility testing to recent deep-lear

272 esis (PFGE) following SmaI macrorestriction, antimicrobial susceptibility testing, urease production,

273 human clinical specimens, were subjected to antimicrobial susceptibility testing using a MicroScan W

274 We present a method for rapid and scalable antimicrobial susceptibility testing using stationary na

275 Antimicrobial susceptibility testing using the agar dilu

276 Antimicrobial susceptibility testing using the Sensititr

277 Antimicrobial susceptibility testing was also conducted.

278 Antimicrobial susceptibility testing was conducted for E

279 lobacter spp. and E. coli were isolated, and antimicrobial susceptibility testing was conducted using

280 e using standard microbiology techniques and antimicrobial susceptibility testing was conducted using

281 e and SCCmec typing were assessed by PCR and antimicrobial susceptibility testing was done according

282 Antimicrobial susceptibility testing was performed by Se

283 Antimicrobial susceptibility testing was performed by st

284 Antimicrobial susceptibility testing was performed follo

285 Antimicrobial susceptibility testing was performed on 21

286 Antimicrobial susceptibility testing was performed on Bc

287 Antimicrobial susceptibility testing was performed using

288 Antimicrobial susceptibility testing was performed using

289 Antimicrobial susceptibility testing was performed, and

290 Antimicrobial susceptibility testing was used to define

291 Phenotypic serotyping and antimicrobial susceptibility testing were conducted, fol

292 Whole genome sequencing and antimicrobial susceptibility testing were done on 168 co

293 ngoing national surveillance, serotyping and antimicrobial susceptibility testing were done on all pn

294 culture, manual speciation, serotyping, and antimicrobial susceptibility testing were performed at M

295 Pneumococcal serotyping and antimicrobial susceptibility testing were performed on 4

296 apid ID 32 Strep identification methods; and antimicrobial susceptibility testing were performed on t

297 Whole genome sequencing (WGS) and antimicrobial susceptibility testing were performed to e

298 Culture-based identification methods and antimicrobial susceptibility testing were used as the re

299 Antimicrobial susceptibility testing, whole-genome seque

300 od, Mo.), an established automated method of antimicrobial susceptibility testing with the ability to